NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Arctic Vision

Arctic Vision

Private
ShanghaiHealthcare & Life Scienceshttps://www.arcticvision.com/

Last Round

Series B

Mar 9, 2021

Total Funding Raised

$132M

Company Overview

Arctic Vision is a biotechnology company that develops and commercializes innovative ophthalmic therapies and medical devices for retinal diseases, dry eye, and ocular neuroprotection.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Hardware Sales

AI Layer

Non-AI

Keywords

ophthalmologybiopharmaceuticaleye caremedical devicesuveitis treatmentmyopia managementintraocular lensesIOLophthalmic therapeuticsrefractive surgeryeye healthvision careclinical developmentin-licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arctic Vision Comps

Public and private peers based on sector, stage, and business model.

Arctic Vision comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Arctic Vision Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 9, 2021
Series AJul 13, 2020
SeedMay 1, 2019

Key People

Founding team and executive leadership

Qing Liu

Chief Medical Officer, Co-founder

Founding Team

Eddy Wu

Founder, Chairman CEO

Founding Team

Arctic Vision Investors

Notable investors and investment history

Arctic Vision investors
InvestorRounds
Loyal Valley CapitalSeries B
Morningside VenturesSeries B, Series A
Nan Fung Life SciencesSeries B, Series A, Seed
Nan Fung GroupSeries B, Series A
Octagon Capital AdvisorsSeries B
Octagon CapitalSeries B
Pivotal bioVenture Partners ChinaSeries B, Series A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 17, 2025

    Attended Hurun Global Gazelles 2024 and received an award.

  • Jan 17, 2025

    Won the Hurun Global Gazelles 2024 award.

Arctic Vision Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Arctic Vision Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Arctic Vision's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range27
Year Founded2019
Last FundingMar 9, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.